Lab
Laboratorio Clinico Caribe Medical Plaza,inc.
Laboratorio Clinico Caribe Medical Plaza,inc. was paid $615K by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 16% of everything it billed.
33Billing provider infoLABORATORIO CLINICO CARIBE MEDICAL PLAZA,INC.
VEGA ALTA, PR 00692
VEGA ALTA, PR 00692
33aNPI1841356367assigned 12/29/2006
33bProvider typeClinical Medical Laboratory
28Total paid$615K
24GClaims51,817
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#217 of 777
Median peer was paid$278K
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RODRIGUEZ, MARIA controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,621 | $70K | |
| 2019 | 5,125 | $48K | |
| 2020 | 4,786 | $49K | |
| 2021 | 6,369 | $82K | |
| 2022 | 8,476 | $133K | |
| 2023 | 9,383 | $112K | |
| 2024incomplete | 10,057 | $122K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 16% | 2,416 | 2,201 | $101K |
| 84443 | Thyroid stimulating hormone (TSH) | 14% | 5,246 | 4,928 | $86K |
| 80061 | Lipid panel | 12% | 5,486 | 5,123 | $73K |
| 80053 | Comprehensive metabolic panel | 10% | 6,001 | 5,514 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.3% | 6,642 | 5,944 | $51K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.6% | 2,958 | 2,760 | $28K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.3% | 2,012 | 1,079 | $26K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.1% | 948 | 873 | $25K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.1% | 1,110 | 1,004 | $25K |
| 81000 | 3.4% | 6,473 | 5,993 | $21K | |
| 86738 | 3.0% | 1,191 | 1,101 | $18K | |
| 82274 | 2.2% | 869 | 789 | $13K |
37 more codes
| 85027 | 1.8% | 1,711 | $11K | |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 1,697 | $10K |
| 84153 | 1.2% | 381 | $7K | |
| 84439 | 1.1% | 745 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 859 | $7K |
| 82043 | <1% | 999 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 640 | $5K |
| 86769 | <1% | 387 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 109 | $5K |
| 86701 | <1% | 467 | $4K | |
| 86328 | <1% | 213 | $4K | |
| 84436 | <1% | 421 | $3K | |
| 80074 | <1% | 53 | $2K | |
| 84479 | <1% | 309 | $2K | |
| 82570 | <1% | 175 | $935.98 | |
| 86696 | <1% | 47 | $756.42 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 20 | $697.38 |
| 83970 | <1% | 21 | $693.54 | |
| 86592 | <1% | 154 | $636.97 | |
| 84152 | <1% | 29 | $587.66 | |
| 86695 | <1% | 47 | $524.60 | |
| 82607 | <1% | 33 | $457.37 | |
| 85610 | <1% | 44 | $172.96 | |
| 85730 | <1% | 30 | $172.92 | |
| 84550 | <1% | 22 | $117.64 | |
| 85651 | <1% | 28 | $99.26 | |
| 82947 | <1% | 26 | $96.50 | |
| 82565 | <1% | 17 | $89.27 | |
| 82270 | <1% | 26 | $83.74 | |
| 84520 | <1% | 17 | $68.67 | |
| 82042 | <1% | 12 | $67.68 | |
| 3044F | 0% | 53 | $0.00 | |
| 3049F | 0% | 39 | $0.00 | |
| 3048F | 0% | 47 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 543 | $0.00 |
| 3045F | 0% | 17 | $0.00 | |
| 3050F | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRODRIGUEZ, MARIA (OWNER,LABORATORY SUPERVISOR)
| Provider | Location | Paid |
|---|---|---|
| First Choice In-Home Care, LLC | Donna, TX | $49.20M |
| Care Counseling Center | Bridgewater, NJ | $2.12M |
| Maria Elena Rodriguez, M.D. P.A. | Edinburg, TX | $1.79M |
| Yorkville Endoscopy, LLC | New York, NY | $1.04M |
| First Choice Medical Supply & Equipment, LLC. | Donna, TX | $693K |
| Mundo Chico Pediatric Associates, LLC | Union City, NJ | $329K |
| Cardiovascular Consultants of Fresno, a Professional Corporation | Fresno, CA | $212K |
| Centro De Gastroenterologia Pediatrica Del Oeste | Mayaguez, PR | $180K |
| Honest Care Health Services LLC | Doral, FL | $85K |
| Laboratorio Clinico Elena LLC | Ponce, PR | $57K |
| Rodmart Optical, INC | San German, PR | $10K |
| Rios Laboratory INC. | San Sebastian, PR | $2K |
| Lab Clinico Villanueva | Isabela, PR | $113.10 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.